<sod >In addition, AstraZeneca is eligible to receive as much as $250 million in milestone payments, up to $600 million in sales-related payments, as well as certain royalties.< eod>< sod > In addition, AstraZeneca is eligible to receive as much as $250m (Â£188m) in milestone payments, up to $600m (Â£453m) in sales-related payments, as well as certain royalties.< eod>